Pfizer Inc. today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of BRAFTOVI® (encorafenib) in combination with cetuximab ...
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...
Imatinib mesylate, a protein tyrosine kinase inhibitor, can induce caspase-independent ... expressed by glioblastoma cells increased the sensitivity to inducers of cell death 87.
Following the incubation in the absence (control) or presence of inhibitors, the reactions were terminated ... above show that CYP2D6 activity is not increased by the classical inducers of the CYP2B, ...
Saudi Arabia’s billion-dollar-a-year healthspan initiative, the Hevolution Foundation, has unveiled a sweeping portfolio of ...
Specifically, activation of caspase 3 leads to the breakdown of several cytoskeletal proteins, cleavage of poly (ADP-ribose) polymerase (PARP) and degradation of ICAD (inhibitor of caspase ...
It has been demonstrated that the occurrence or magnitude of sign epistasis can be altered by the environment, including the presence of inducers or inhibitors (Baier et al., 2023) and antibiotics ...
New Drug Research & Development Co. Ltd. have identified molecular glue degraders comprising cereblon (CRBN) ligands acting as eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) ...
Arsenal delivered a statement of intent in the Premier League title race with a 5-1 hammering of champions Manchester City to close the gap at the top to six points on Sunday. Captain Martin ...
Lenovo’s Legion Go S was one of the worst-kept secrets for CES 2025, but now we don’t need to pretend anymore, as we’ve not only seen it in the flesh, but we’ve had enough time to give it ...
Merck Sharp & Dohme LLC has identified targeted activator of cell kill (TACK) compounds acting as Gag polyprotein (HIV-1)/protein Pol dimerization inducers reported to be useful for the treatment of ...
Correspondence to Dr Pere Ginès, Liver Unit, Hospital Clinic of Barcelona, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona 08036, Spain; ...